Redmile Group, LLC
Source: SEC Form 13F · as of Mar 2026Redmile Group, LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $1.05B in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$1.05B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Scholar Rock Holding Corp (SRRK)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| SRRKScholar Rock Holding Corp | 9,066,621 | $445.7M |
| STOKStoke Therapeutics, Inc. | 4,164,120 | $135.6M |
| NRIXNurix Therapeutics, Inc. | 7,732,808 | $119.9M |
| ANNXAnnexon, Inc. | 14,549,768 | $80.6M |
| RGNXREGENXBIO Inc. | 4,368,804 | $36.6M |
| BEAMBeam Therapeutics Inc. | 1,237,659 | $29.5M |
| NGNENeurogene Inc. | 1,459,599 | $29.4M |
| COGTCogent Biosciences, Inc. | 688,036 | $26.5M |
| ABSIAbsci Corporation | 8,253,316 | $24.8M |
| ALXOALX ONCOLOGY HOLDINGS INC | 7,964,188 | $16.0M |
| FATEFATE THERAPEUTICS INC | 12,872,946 | $15.4M |
| SLDBSolid Biosciences Inc. | 2,011,895 | $14.5M |
| NUVBNuvation Bio Inc. | 3,153,256 | $13.5M |
| ZYMEZymeworks Inc. | 491,654 | $12.3M |
| SLNSilence Therapeutics Plc | 2,164,777 | $11.4M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 173,859 | $9.8M |
| CLDXCelldex Therapeutics, Inc. | 261,508 | $8.3M |
| ORICOric Pharmaceuticals, Inc. | 415,710 | $5.3M |
| ARDXARDELYX, INC. | 733,350 | $4.4M |
| IVVDInvivyd, Inc. | 2,648,659 | $3.4M |
| AGMBAgomAb Therapeutics NV | 156,250 | $1.6M |
| PLRXPLIANT THERAPEUTICS, INC. | 772,126 | $973K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.